Craig W. Philips work email
- Valid
- Valid
- Valid
- Valid
- Valid
Craig W. Philips personal email
- Valid
- Valid
Craig W. Philips phone numbers
Senior executive/Board Member with broad based global pharmaceutical/biotechnology experience. Over twenty Years of Big Pharma experience through all stages of drug and corporate evolution. Ten Years of small pharma and start-up experience. Co-Founder/Board member/Advisor for startup companies (PVP Biologics, (sold to Takeda), Abacus Bioscience, MedsForAll, Transcellular Therapeutics) . Today, I am focused on corporate transactions including M&A and strategic transactions, equity financing, developing markets for pharma products, and building and leading highly effective teams. My expertise includes partnering, corporate strategy, market analysis, and fund raising. An overview of my experience includes roles as CEO, COO, President, VP and GM, and Board Member in both large pharma and emerging companies: - Delivered outstanding corporate/clinical/commercial performance- Public company leadership experience and fundraising- Built companies in multiple medical sectors and developed new corporate capabilities- Led strategy, development, franchise positioning and differentiation for new products. - Multiple successful business development and M&A experiences; both transactional and partnerships.- Built high performing teams, lead key staff development for future corporate leaders.- Served on multiple corporate, industry, and nonprofit Boards of Directors.
-
Founding PartnerPack VenturesSeattle, Wa, Us -
PresidentKineta, Inc. 2013 - PresentSeattle, Wa, UsPrivate biotech company focused on developing leading edge therapeutics in high need therapeutic areas for immuno-oncology and chronic pain. Primary corporate focus is discovery and drug development through translational development and into the clinic, followed by corporate partnering. Concluded a $350 million strategic partnering transaction with Genentech for a non-opioid chronic pain drug program and sold a preclinical IO program to Pfizer. -
Founding PartnerPack Ventures 2021 - PresentSeattle, Us -
Board Member, Co-FounderAbacus Bioscience Inc 2015 - PresentSeattle, Wa, Us -
General PartnerWhetstone Ventures Llc 2014 - Present
-
Board MemberCbi Co Ltd 2021 - 2022
-
Entrepreneur-In-ResidenceUniversity Of Washington 2012 - 2017Seattle, Wa, UsProvided UW academic researchers with real-world insights about the technologies in development at the university focusing on financing/development/commercialization process. Collaborate with faculty and spin out companies in life science fields and emerging technologies. Develop corporate strategy, funding plans, and growth/exit plans. Serve as an independent advisor/board member/founder to start-up companies including CanCure LLC, Abacus Biosciences Inc., EnTox Sciences, TransCellular Therapeutics Inc., NovaTheraNostics Inc., and PVP Biologics Inc. including expertise in target markets, product development, and fundraising strategies across life science, IT, and engineering fields.Co-Founder, advisor or board member for life science spin out companies including NovaTheraNostics Inc, PvP Biologics Inc, Abacus Bioscience Inc, EnTox Sciences, CanCure BioPharma Inc and TransCellular Therapeutics Inc. -
Adjunct Professor And Guest LecturerSeattle University 2014 - 2016Seattle, Wa, UsAdjunct faculty role teaching Management Strategy at the Albers School of Business and Economics Management and a lecturer in Business Ethics. Mentor for MBA students interested in careers in life sciences.Seattle University, founded in 1891, is a Jesuit Catholic university and law school More than 7,400 students are enrolled in undergraduate and graduate programs within eight schools and colleges. The Albers School of Business is ranked as one of the top 50 private Business Schools in the nation. -
PresidentCell Therapeutics, Inc. 2008 - 2012Seattle, Wa, UsCTI is committed to developing, acquiring, and commercializing innovative treatments for cancer. My role focused on day-to-day company operations – commercial, finance, clinical, regulatory, manufacturing and fund raising (over $300m raised). Worked closely with CEO/Board on strategic issues relating to corporate partnering, financing, and company strategy, as well as new product development and M&A activities. Extensive interface with the Board of Directors. Closely involved with audit, board development, and governance committees. Principal responsibility for major corporate partnerships (including Novartis, Spectrum, Chroma, Cephalon (Teva)). Successful M&A activity with in- and out-licensing of several products. Successful EU regulatory approval of lead compound. Staff: 75+ -
Vice President And General ManagerBayer Oncology 2006 - 2008Leverkusen, North Rhine-Westphalia, DeHead, US Cancer Portfolio. US P&L Responsibility for solid and liquid cancer drugs with a team of over 150 people (Nexavar, Leukine, Campath, Fludara). Member of the US Executive Committee. Integrated and relocated the Bayer and Berlex oncology organizations in the US. Responsible for leading partnerships with Bayer/Onyx, Bayer/Genzyme, others. -
Vice President And General Manager, Head Us OncologyBerlex Biosciences 2004 - 2007UsP&L responsibility for the oncology business in the US. Member of the Global Oncology Leadership Team. -
General ManagerSchering-Plough Pharmaceuticals Jun 2000 - Dec 2003Global Marketing, launch of Intron A in Hepatitis and Hematology. Head of Hospital/Oncology Business in Canada, GM in Thailand/Laos/Cambodia, GM in Australia and New Zealand. Launch of Intron A, Rebetron, Temodal, Remicade, Asmanex, Nasonex, Claritin D
-
General Manager - ThailandSchering-Plough Pharmaceuticals 1997 - 2000
-
Business Unit Head, Oncology (Canada)Schering-Plough Pharmaceuticals 1992 - 1997
-
Senior Manager Global OncologySchering Plough 1989 - 1992Lead the global commercial launch program for INTRON A in oncology and virology.
-
Marketing And Sales, Oncology, Cns, Antiinfectives, CardiologyBristol Myers 1984 - 1989Lawrence Township, Nj, Us
Craig W. Philips Skills
Craig W. Philips Education Details
-
The Ohio State University Fisher College Of BusinessMasters In Business Administration -
The Ohio State UniversityMarketing -
InseadPharmaceutical Corporate Strategy
Frequently Asked Questions about Craig W. Philips
What company does Craig W. Philips work for?
Craig W. Philips works for Pack Ventures
What is Craig W. Philips's role at the current company?
Craig W. Philips's current role is Founding Partner.
What is Craig W. Philips's email address?
Craig W. Philips's email address is ph****@****leu.edu
What is Craig W. Philips's direct phone number?
Craig W. Philips's direct phone number is +120645*****
What schools did Craig W. Philips attend?
Craig W. Philips attended The Ohio State University Fisher College Of Business, The Ohio State University, Insead.
What are some of Craig W. Philips's interests?
Craig W. Philips has interest in Education, Health.
What skills is Craig W. Philips known for?
Craig W. Philips has skills like Oncology, Pharmaceutical Industry, Biotechnology, Lifesciences, Biopharmaceuticals, Cardiology, Clinical Development, Strategy, Life Sciences, Clinical Trials, Clinical Research, Cancer.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial